|
1
|
Rawla P and Barsouk A: Epidemiology of
gastric cancer: Global trends, risk factors and prevention. Prz
Gastroenterol. 14:26–38. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Deng J, Liang H, Wang D, Sun D, Pan Y and
Liu Y: Investigation of the recurrence patterns of gastric cancer
following a curative resection. Surg Today. 41:210–215.
2011.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Gaspar L, Scott C, Rotman M, Asbell S,
Phillips T, Wasserman T, McKenna WG and Byhardt R: Recursive
partitioning analysis (RPA) of prognostic factors in three
radiation therapy oncology group (RTOG) brain metastases trials.
Int J Radiat Oncol Biol Phys. 37:745–751. 1997.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Abrams Hl, Spiro R and Goldstein N:
Metastases in carcinoma; analysis of 1000 autopsied cases. Cancer.
3:74–85. 1950.PubMed/NCBI View Article : Google Scholar
|
|
5
|
York JE, Stringer J, Ajani JA, Wildrick DM
and Gokaslan ZL: Gastric cancer and metastasis to the brain. Ann
Surg Oncol. 6:771–776. 1999.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Foster RL: Reporting guidelines: CONSORT,
PRISMA, and SQUIRE. J Spec Pediatr Nurs. 17:1–2. 2012.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Amir-Behghadami M and Janati A:
Population, intervention, comparison, outcomes and study (PICOS)
design as a framework to formulate eligibility criteria in
systematic reviews. Emerg Med J. 37(387)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Bae JM: A suggestion for quality
assessment in systematic reviews of observational studies in
nutritional epidemiology. Epidemiol Health.
38(e2016014)2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Kasakura Y, Fujii M, Mochizuki F, Suzuki T
and Takahashi T: Clinicopathological study of brain metastasis in
gastric cancer patients. Surg Today. 30:485–490. 2000.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Qiu MZ, Shi SM, Chen ZH, Yu HE, Sheng H,
Jin Y, Wang DS, Wang FH, Li YH, Xie D, et al: Frequency and
clinicopathological features of metastasis to liver, lung, bone,
and brain from gastric cancer: A SEER-based study. Cancer Med.
7:3662–3672. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Li Y, Xie D, Chen X, Hu T, Lu S and Han Y:
Prognostic value of the site of distant metastasis and surgical
interventions in metastatic gastric cancer: A population-based
study. Technol Cancer Res Treat.
19(1533033820964131)2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Ishizuka Y, Omori T, Shinno N, Yamamoto M,
Hara H, Otsuka T, Nishio M, Nishida N, Fujisawa F, Sugimoto N, et
al: Early detection of brain metastases and appropriate local
therapy followed by systemic chemotherapy may improve the prognosis
of gastric cancer. Sci Rep. 13(20805)2023.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Baccili Cury Megid T, Baskurt Z, Ma LX,
Barron CC, Farooq A, Saltiel MP, Wang X, Bach Y, Ayoama H, Jang RW,
et al: Leptomeningeal carcinomatosis and brain metastases in
gastroesophageal carcinoma: A real-world analysis of clinical and
pathologic characteristics and outcomes. J Neurooncol. 167:111–122.
2024.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Global Burden of Disease Cancer
Collaboration. Fitzmaurice C, Abate D, Abbasi N, Abbastabar H,
Abd-Allah F, Abdel-Rahman O, Abdelalim A, Abdoli A, Abdollahpour I,
et al: Global, regional, and national cancer incidence, mortality,
years of life lost, years lived with disability, and
disability-adjusted life-years for 29 cancer groups, 1990 to 2017:
A systematic analysis for the global burden of disease study. JAMA
Oncol. 5:1749–1768. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Riihimäki M, Hemminki A, Sundquist K,
Sundquist J and Hemminki K: Metastatic spread in patients with
gastric cancer. Oncotarget. 7:52307–52316. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Davis FG, Dolecek TA, McCarthy BJ and
Villano JL: Toward determining the lifetime occurrence of
metastatic brain tumors estimated from 2007 United States cancer
incidence data. Neuro Oncol. 14:1171–1177. 2012.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Japanese Gastric Cancer Association.
Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric
Cancer. 14:113–123. 2011.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Guo Q, Li Q, Wang J, Liu M, Wang Y, Chen
Z, Ye Y, Guan Q and Zhou Y: A comprehensive evaluation of clinical
efficacy and safety of celecoxib in combination with chemotherapy
in metastatic or postoperative recurrent gastric cancer patients: A
preliminary, three-center, clinical trial study. Medicine
(Baltimore). 98(e16234)2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Liu G, Xu M, Gao T, Xu L, Zeng P, Bo H, Li
F, Zhang W and Wang Z: Surgical compliance and outcomes in gastric
cancer: A population-based cohort study. J Cancer. 10:779–788.
2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Inoue K, Nakane Y, Kogire M, Fujitani K,
Kimura Y, Imamura H, Tamura S, Okano S, Kwon AH, Kurokawa Y, et al:
Phase II trial of preoperative S-1 plus cisplatin followed by
surgery for initially unresectable locally advanced gastric cancer.
Eur J Surg Oncol. 38:143–149. 2012.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Yamaguchi K, Yoshida K, Tanahashi T,
Takahashi T, Matsuhashi N, Tanaka Y, Tanabe K and Ohdan H: The
long-term survival of stage IV gastric cancer patients with
conversion therapy. Gastric Cancer. 21:315–323. 2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Luo D, Liu Q, Yu W, Ma Y, Zhu J, Lian P,
Cai S, Li Q and Li X: Prognostic value of distant metastasis sites
and surgery in stage IV colorectal cancer: A population-based
study. Int J Colorectal Dis. 33:1241–1249. 2018.PubMed/NCBI View Article : Google Scholar
|
